Effect of dexketoprofen on analgesic concentration of oxycodone after laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-002085-39-FI

Enrollment

Unknown

Registered

2013-06-05

Start date

2013-07-09

Completion date

Unknown

Last updated

2016-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis MedDRA version: 14.1 Level: PT Classification code 10008629 Term: Cholelithiasis System Organ Class: 10019805 - Hepatobiliary disorders

Interventions

Trade Name: Ketesse Pharmaceutical Form: Concentrate and solvent for solution for injection/infusion INN or Proposed INN: DEXKETOPROFEN (AS TROMETAMOL) CAS Number: 156604-79-4 Trade Name: Oxanest Ph

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 24 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: not applicable;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactHospital

Kuopio University Hospital

hannu.kokki@kuh.fi+358447174654

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026